The Trump administration’s Centers for Medicare & Medicaid Services (CMS) has signaled that it will be revamping the process ...

The new Trump administration should seize the opportunity to change the Medicare drug price negotiation program by ...

The second round of Medicare Part D price negotiations will feature two drugs familiar to rheumatologists — Ofev and Otezla — ...

Democrats sought answers from RFK Jr. on how the Trump administration would handle Medicare price negotiations after a short ...

As the next round of Medicare drug pricing negotiations get underway, experts predict President Trump may seek to weaken the program.

President Trump will continue to pursue the policy of Medicare ... said the CMS in its statement. Trump is planning to issue an executive order supporting drug price negotiations under the IRA ...

AAM said that by including drugs with generics and biosimilars in development in the 15 drugs selected for negotiation, CMS ...

President Donald Trump’s Medicare agency is seeking to bring more transparency to the US government’s drug price negotiation ...

Robert F. Kennedy Jr. said he would follow the Trump administration’s orders on prescription drug price negotiations, a ...

Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for older adults and people with disabilities.

According to the survey cited by NCPA, 60.4% of independent pharmacists are considering not stocking one or more of the first ...

Medicare beneficiaries may pay less for 15 additional prescription drugs as early as 2027 as part of the next round of federal regulators' price negotiations with pharmaceutical manufacturers.